Related Experiment Video
Updated: Oct 27, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Successful management of post-COVID-19 acanthamoebic encephalitis
Govinda Siripurapu1, Sameer Abdul Samad2, Saman Fatima1
1Department of Neurology, AIIMS New Delhi, Delhi, India.
None:
Acanthamoebic encephalitis is a rare and highly fatal disease that has no standard management protocol. Coronavirus disease 2019 (COVID-19) causes immune dysfunction and may predispose patients to this infection. The present study describes successful management of acanthamoebic encephalitis in a young male who recently recovered from COVID-19 using a combination of medical and surgical approaches. A combination of miltefosine with other agents with trophicidal and cysticidal activities should be used in the regimen. Surgical excision of the abscess should be undertaken whenever feasible.
Related Concept Videos
Tonsillitis II: Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Myocarditis III: Medical Management
Acute Pancreatitis II: Clinical Manifestations and Management
Endocarditis III: Medical Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

